Ceftaroline Activity Against Multidrug-Resistant Streptococcus pneumoniae from U.S. Medical Centers (2014) and Molecular Characterization of a Single Ceftaroline Nonsusceptible Isolate-Reference-Cited by-同舟云学术

Ceftaroline Activity Against Multidrug-Resistant Streptococcus pneumoniae from U.S. Medical Centers (2014) and Molecular Characterization of a Single Ceftaroline Nonsusceptible Isolate

Published:2017-07 Issue:5 Volume:23 Page:571-579
ISSN:1076-6294
Container-title:Microbial Drug Resistance
language:en
Short-container-title:Microbial Drug Resistance

Author:

Pfaller Michael A.¹²,Mendes Rodrigo E.¹,Flamm Robert K.¹,Jones Ronald N.¹,Sader Helio S.¹

Affiliation:

1. JMI Laboratories, North Liberty, Iowa.

2. University of Iowa, Iowa City, Iowa.

Publisher

Mary Ann Liebert Inc

Subject

Microbiology (medical),Pharmacology,Immunology,Microbiology

Link

http://www.liebertpub.com/doi/pdf/10.1089/mdr.2016.0258

Reference35 articles.

1. Burden of Community-Acquired Pneumonia in North American Adults

2. Decreased Ceftriaxone Susceptibility in Emerging (35B and 6C) and Persisting (19A) Streptococcus pneumoniae Serotypes in the United States, 2011-2012: Ceftaroline Remains ActiveIn Vitroamong β-Lactam Agents

3. Update on antimicrobial susceptibility trends among Streptococcus pneumoniae in the United States: report of ceftaroline activity from the SENTRY Antimicrobial Surveillance Program (1998–2011)

4. AWARE Ceftaroline Surveillance Program (2008–2010): Trends in Resistance Patterns Among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States

5. Changes in Pneumococcal Serotypes and Antimicrobial Resistance after Introduction of the 13-Valent Conjugate Vaccine in the United States

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibiotic Resistance to Molecules Commonly Prescribed for the Treatment of Antibiotic-Resistant Gram-Positive Pathogens: What Is Relevant for the Clinician?;Pathogens;2024-01-19

2. Antimicrobial Resistance: An Overview;Nanotechnology Based Strategies for Combating Antimicrobial Resistance;2024

3. Ceftaroline fosamil – fifth-generation cephalosporin with anti-MRSA activity in the treatment of severe infections in pediatric practice;Clinical Microbiology and Antimicrobial Chemotherapy;2024

4. Antimicrobial Activity of Ceftaroline and Comparator Agents Against Ceftriaxone-Nonsusceptible Streptococcus pneumoniae from the United States (2008–2020);Microbial Drug Resistance;2022-09-01

5. Ceftaroline Fosamil for Treatment of Pediatric Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia;Pediatric Drugs;2021-08-31